It has also been investigated, how many teams used antibodies in their 2014 project in regards to the regions, the result is represented in the chart. It is seen, that though Europe only represents 28% of the total teams, these team use antibodies significantly more at 55% out of all teams. Whereas North American teams used antibodies in their project half as much as the total representation of teams.

There could be several reasons for this under- and overrepresentation. If it is assumed, that all teams producing proteins could potentially use antibodies, it is a possibility that projects on this subject is more common in Europe than in North America, in the chart it can be seen that this is not the case. North American and European teams producing protein are distributed with 34% and 37% respectively. Therefore another reason must responsible for the uneven usage of antibodies in the regions.

To identify these reasons the production of proteins has been compared to the usage of antibodies, this is presented in the chart. This chart clearly shows, that the usage of antibodies is far less common than the production of proteins. Since it has already been assumed that all teams producing proteins could potentially use antibodies, the market should be evaluated by the protein production not the antibody usage.

The reasons that antibodies are rarely used are plenty. Teams might not have reached a point in their research, where antibodies can be applied to the experiments. This should not be considered in the evaluation of the market, since it is assumed that research projects normally have more time to evolve. It is more likely that the cause is the expense or the long delivering time of antibodies that are not readily available.

Therefore it is estimated that the market includes all teams producing proteins. In all 123 teams where involved in such projects, and on average the teams used two types of antibodies per project. Therefore a production of approximately 246 varieties of peptide aptamers is presumed appropriate. Though this estimates the number of batches per year, each project will only buy a small amount of the production. Therefore it should be evaluated if, it is reasonable to assume that the rest of the production can be sold as well. To reach a conservative estimate the European market has been evaluated, as this is the region where most antibodies where used by iGEM teams from 2014. There were 63 universities represented at iGEM 2014 out of approximately 4000 academic institutions in Europe. Reference: European Union. The role of universities in the Europe of knowledge. (Link) (Accessed August 21^st 2015). Taking these numbers into account iGEM 2014 represents 1.6% of the market. This is assuming that only one research project per university is using antibodies, which is unlikely. This evaluation reinforces the assumption, that the remaining product can be sold. In some instances this will not be the case, due to the specialized nature of production or property rights on the protein targetet, therefore it is estimated that 30% of the production will be lost.

To estimate how much capital is needed to build the plant, the model Busche (1995) with modifications has been used. Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010 The size of the factory has to be estimated before costs can be calculated, therefore it is necessary to evaluate the number of units needed. As established under entrepreneurship it has been decided to produce several small batches, and the market analysis estimated the amount of batches to be 250 [batches/yr]. According to the timeline a batch cycle is 63.5 [h], and the next batch can begin after a flash sterilization of the fermenter, after 42.5 [h] from the start of the batch. This will say, that the cycle time for two batches is 106 [h]. It is assumed that the plant is closed for 4 [weeks/yr] and a work week consists of 5 days (120 [h]). Which means that 3 set-ups is needed. This assumption leaves a time buffer in case of unforeseen maintenance or orders.

Table 1: Estimate of the total capital investment

	Result [million USD]	Source:
Total bare-module investment	7.6	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   chapter 22.3 Simulation Aspen Plus, method BK10 Reference: E-mail from GE lifescienses   linear extrapolation of price development
Cost of site preparation	1.1	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   chapter 22.3
Cost of service facilities	0.6	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   chapter 22.3
Allocated costs for utility plants and related facilities	2.9	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   chapter 22.3; table 22.12 Simulation Aspen Plus, method BK10
Total direct permanent investment (CDPI)	12.2	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   chapter 22.3
Cost of contingencies and contractor’s fee	2.2	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   chapter 22.3
Total depreciable capital (CTDC)	14.4	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   chapter 22.3
Cost of land	0.3	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   chapter 22.3
Cost of plant startup	3.6	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   chapter 22.3
Total permanent investment (CTPI)	21.6	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010  chapter 22.3
Working capital	3.2	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   chapter 22.3
Total captital investment (CTCI)	24.9	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   chapter 22.3

This calculation shows that an investment of 24.9 [million USD] is needed to get the plant up and running. From this amount 14.4 [million USD] is depreciable.

Now it needs to be approximated how much it will cost PAST to run production annually, this is achieved by usage of a model, Busche (1995) with modifications. Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010

Table 2:

	Result [million USD/yr]	Source:
Total Feedstock	3.5	Entrepreneurship
		Reference: Available at: [Sigma-Aldrich] (accessed: 10.09.2015)   Sigma-Aldrich
		Reference: Available at: [NEB] (accessed: 13.09.2015)   NEB
Electricity	0.3	Simulation Aspen Plus, methods BK10 and Water
Cooling water	0.00004	Simulation Aspen Plus, methods BK10 and Water
Process water	0.003	Entrepreneurship
Total utilities	0.32	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Direct wages and benefits	1.09	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Equation 23.2 and table 23.3
Direct salaries and benefits	0.16	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Operating supplies and services	0.07	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Technical assistance to manufacturing	0.02	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Control laboratory	0.02	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Total labor-related Operations (O)	1.4	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Wages and benefits	0.6	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Salaries and benefits	0.2	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Materials and services	0.6	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Maintenance overhead	0.03	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Total Maintenance (M)	1.5	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
General plant overhead	0.1	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Mechanical department services	0.05	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Employee relations department	0.1	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Business services	0.2	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Total operation overhead	0.47	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Property taxes and insurance (t)	0.3	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Direct plant	0.88	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Allocated plant	0.21	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Total depreciation (D)	1.08	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2
Total cost of manufacturing (COM)	8.6	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010  Chapter 23.2
Total general expenses (GE)	0.2	Reference: Available at: (accessed: 15.09.2015)   Rand Corporation
Total cost of production (C)	8.8	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010   Chapter 23.2

This concludes that according to this model, it will cost 8.8 [million USD/yr] for PAST to produce 250 batches.

The challenge of biotech companies is to price a product that is of yet not on the market. This has to be an evaluation of the costs estimated above and the investments needed for maturing the concept on the one hand. On another how much customers are willing to pay. PAST aims to replace mAbs, and it must be assumed that though there are concerns of animal welfare, the customers will be inclined to keep using mAbs, if the price of the peptide aptamers are not considerably lower. Therefore an average of the price mAbs has been estimated by 50 products from Sigma-Aldrich, details can be viewed in pdf. Showing an average price of 1.7 [million USD/g]. This method of pricing presupposed that the peptide aptamers have the same affinity and specificity as mAbs. The definition of sales can be viewed in equation 1, it should be noted, that it is assumed that 30 % of production is lost. Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010

S=Price x 0.70Production (1)

In the figure the development of sales and net earnings in relation to a price of 1-100% of that of mAbs can be viewed. Net earnings has been calculated from equation 2. Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010

Net earnings = (1 - t)(S - C) (2)

This confirms the assumption, that this production method can render profit at a price lower than that of mAbs. Though it does not take into account the investments in the plant. Therefore three different methods are used for estimating the profitability, see table. These methods cannot be compared directly, but if all shows profitability, it must be assumed, that grounds to work further with the idea is established. Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010

Table 3: methods of evaluating profitability

Method	Equation	Source
Return of investment	ROI=(1-t)(S-C)/CTCI	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010  table 22.5
Payback period	PBP=CTDC/((1-t)(S-C)+D)	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010  table 22.5
Venture profit	VP=(1-t)(S-C)-imin CTCI	Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010  table 22.5

The goal is to sell the peptide aptamers at least at 50% of the price of mAbs, therefore the methods are used for a price range between 1-50 %. Parameters for profitability of the three methods are: ROI>0 %, PBP<2 [yr] and VP>0 [million/yr]. Results can viewed in figure. Reference: Seider, Seader, Lewin and Widagoo. Product and Process Design Principles - Synthesis, Analysis, and Evaluation; Third Edition - International Student Version; John Wiley & Sons, Inc.; 2010

The evaluation shows, that P. A. S. T. will be profitable at a price above 4 % that of mAbs, which corresponds to a price of 0.07 [million USD/g]. It is most unlikely that investors can be paid back at this price, and should be taken as an indication of the margin in pricing. In this estimate it will be possible to raise prices by 44% before exceeding the goal. Another uncertainty is the validity of the estimate, since this is only an approximation of reality. Therefore the same calculations were done, if the cost turns out to be double. This showed profitability at a price set at 8% that of mAbs, which corresponds to a price of 0.13 [million USD/g]. This leads to the conclusion, that there is a good possibility of making a profitable enterprise, and it should be encourage to keep working towards more accurate estimates and finally the realization of P. A. S. T.